首页> 外文期刊>European journal of heart failure: journal of the Working Group on Heart Failure of the European Society of Cardiology >Use of non-vitamin K antagonist oral anticoagulants in patients with heart failure and atrial fibrillation: does concomitant kidney disease change our practice?

【24h】

Use of non-vitamin K antagonist oral anticoagulants in patients with heart failure and atrial fibrillation: does concomitant kidney disease change our practice?

机译：非维生素K拮抗剂口服抗凝剂在心力衰竭和心房颤动患者中的使用：伴随的肾脏疾病会改变我们的做法吗？

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《European journal of heart failure: journal of the Working Group on Heart Failure of the European Society of Cardiology》 |2016年第9期|共3页
作者
Shahid Farhan; Shantsila Eduard; Lip Gregory Y. H.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Use of non-vitamin K antagonist oral anticoagulants in patients with heart failure and atrial fibrillation: does concomitant kidney disease change our practice? [J] . Shahid Farhan, Shantsila Eduard, Lip Gregory Y. H. European journal of heart failure: journal of the Working Group on Heart Failure of the European Society of Cardiology . 2016,第9期

机译：非维生素K拮抗剂口服抗凝剂在心力衰竭和心房颤动患者中的使用：伴随的肾脏疾病会改变我们的做法吗？
2. Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study [J] . Emma Kirstine Laugesen, Laila Staerk, Nicholas Carlson, Thrombosis Journal . 2019,第1期

机译：非维生素K拮抗剂口腔抗凝血剂与心房颤动和慢性肾病患者的维生素-K拮抗剂：全国范围内的队列研究
3. Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group [J] . Pharithi Rebabonye B., Ranganathan Deepti, OBrien Jim, Irish journal of medical science . 2019,第1期

机译：处方是否正确？非瓣膜心房颤动患者的非维生素K拮抗剂抗凝血剂（NOAC）处方述评。心房颤动和卒中中非维生素K口腔抗凝血剂的心房颤动和评价安全规定（安全Noacs）组
4. Self-management of Oral Anticoagulants by Patients with Atrial Fibrillation: How Effective and Safe Is It? [C] . R. Cazzin, P. Serra C. Lestuzzi International Workshop on Cardiac Arrhythmias . 2002

机译：心房颤动患者的口腔抗凝血剂自我管理：它有多效益和安全？
5. Switching from Vitamin K Antagonists to Non-vitamin K Oral Anticoagulants, Drug-Drug Interactions, and Health Outcomes among Working-Age Adults with Atrial Fibrillation [D] . Feng, Xue. 2018

机译：从维生素K拮抗剂切换到非维生素K口服抗凝剂，药物 - 药物相互作用，以及具有心房颤动的工作年龄成年人之间的健康状况
6. Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study [O] . Emma Kirstine Laugesen, Laila Staerk, Nicholas Carlson, 2019

机译：房颤和慢性肾脏病患者中非维生素K拮抗剂口服抗凝剂与维生素K拮抗剂的比较：一项全国队列研究
7. Use of non-vitamin K antagonist oral anticoagulants in patients with heart failure and atrial fibrillation:does concomitant kidney disease change our practice? [O] . Shahid Farhan, Shantsila Eduard, Lip Gregory Y H 2016

机译：在心力衰竭和心房颤动患者中使用非维生素K拮抗剂口服抗凝药：伴随肾脏疾病会改变我们的做法吗？

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号